Titre : Récepteurs purinergiques P1

Récepteurs purinergiques P1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteurs purinergiques P1 : Questions médicales les plus fréquentes", "headline": "Récepteurs purinergiques P1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteurs purinergiques P1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-21", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteurs purinergiques P1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs purinergiques", "url": "https://questionsmedicales.fr/mesh/D011983", "about": { "@type": "MedicalCondition", "name": "Récepteurs purinergiques", "code": { "@type": "MedicalCode", "code": "D011983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Récepteur A1 à l'adénosine", "alternateName": "Receptor, Adenosine A1", "url": "https://questionsmedicales.fr/mesh/D043682", "about": { "@type": "MedicalCondition", "name": "Récepteur A1 à l'adénosine", "code": { "@type": "MedicalCode", "code": "D043682", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700.700.100" } } }, { "@type": "MedicalWebPage", "name": "Récepteurs A2 à l'adénosine", "alternateName": "Receptors, Adenosine A2", "url": "https://questionsmedicales.fr/mesh/D043683", "about": { "@type": "MedicalCondition", "name": "Récepteurs A2 à l'adénosine", "code": { "@type": "MedicalCode", "code": "D043683", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700.700.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Récepteur A2A à l'adénosine", "alternateName": "Receptor, Adenosine A2A", "url": "https://questionsmedicales.fr/mesh/D043705", "about": { "@type": "MedicalCondition", "name": "Récepteur A2A à l'adénosine", "code": { "@type": "MedicalCode", "code": "D043705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700.700.200.100" } } }, { "@type": "MedicalWebPage", "name": "Récepteur A2B à l'adénosine", "alternateName": "Receptor, Adenosine A2B", "url": "https://questionsmedicales.fr/mesh/D043704", "about": { "@type": "MedicalCondition", "name": "Récepteur A2B à l'adénosine", "code": { "@type": "MedicalCode", "code": "D043704", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700.700.200.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Récepteur A3 à l'adénosine", "alternateName": "Receptor, Adenosine A3", "url": "https://questionsmedicales.fr/mesh/D043684", "about": { "@type": "MedicalCondition", "name": "Récepteur A3 à l'adénosine", "code": { "@type": "MedicalCode", "code": "D043684", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.700.700.300" } } } ], "about": { "@type": "MedicalCondition", "name": "Récepteurs purinergiques P1", "alternateName": "Receptors, Purinergic P1", "code": { "@type": "MedicalCode", "code": "D018047", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Wen-Jun Zhang", "url": "https://questionsmedicales.fr/author/Wen-Jun%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Rehabilitation Medicine, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province, China." } }, { "@type": "Person", "name": "Janielle P Maynard", "url": "https://questionsmedicales.fr/author/Janielle%20P%20Maynard", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. maynard@jhmi.edu." } }, { "@type": "Person", "name": "Si-Jian Lin", "url": "https://questionsmedicales.fr/author/Si-Jian%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Rehabilitation Medicine, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province, China." } }, { "@type": "Person", "name": "Peter Illes", "url": "https://questionsmedicales.fr/author/Peter%20Illes", "affiliation": { "@type": "Organization", "name": "School of Acupuncture and Tuina, Chengdu University of Traditonal Chinese Medicine, Chengdu 610075, China; Rudolf Boehm Institute for Pharmacology and Toxicology, University of Leipzig, 04107 Leipzig, Germany; International Joint Research Center for Purinergic Signaling, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China. Electronic address: Peter.illes@medizin.uni-leipzig.de." } }, { "@type": "Person", "name": "Henning Ulrich", "url": "https://questionsmedicales.fr/author/Henning%20Ulrich", "affiliation": { "@type": "Organization", "name": "International Joint Research Center for Purinergic Signaling, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China; Department of Biochemistry and Molecular Biology, Chemistry Institute, University of Sao Paulo (USP), Sao Paulo, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Preemptive analgesia for hemorrhoidectomy: study protocol for a prospective, randomized, double-blind trial.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35761383", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06107-0" } }, { "@type": "ScholarlyArticle", "name": "Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37466211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/head.14600" } }, { "@type": "ScholarlyArticle", "name": "Clonidine augmentation in patients with schizophrenia: A double-blind, randomized placebo-controlled trial.", "datePublished": "2023-03-28", "url": "https://questionsmedicales.fr/article/36989672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.schres.2023.03.039" } }, { "@type": "ScholarlyArticle", "name": "Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder.", "datePublished": "2023-02-22", "url": "https://questionsmedicales.fr/article/36856701", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1176/appi.ajp.20220737" } }, { "@type": "ScholarlyArticle", "name": "Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.", "datePublished": "2022-12-03", "url": "https://questionsmedicales.fr/article/36462055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00415-022-11501-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs aux neuromédiateurs", "item": "https://questionsmedicales.fr/mesh/D017981" }, { "@type": "ListItem", "position": 7, "name": "Récepteurs purinergiques", "item": "https://questionsmedicales.fr/mesh/D011983" }, { "@type": "ListItem", "position": 8, "name": "Récepteurs purinergiques P1", "item": "https://questionsmedicales.fr/mesh/D018047" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteurs purinergiques P1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteurs purinergiques P1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Récepteurs purinergiques P1", "description": "Comment diagnostiquer une dysfonction des récepteurs P1 ?\nQuels examens sont utilisés pour évaluer les récepteurs P1 ?\nLes imageries sont-elles utiles pour les récepteurs P1 ?\nY a-t-il des biomarqueurs pour les récepteurs P1 ?\nComment évaluer l'activité des récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Récepteurs purinergiques P1", "description": "Quels symptômes sont liés à une dysfonction des récepteurs P1 ?\nLes douleurs chroniques sont-elles associées aux récepteurs P1 ?\nY a-t-il des signes d'inflammation liés aux récepteurs P1 ?\nLes troubles du sommeil sont-ils liés aux récepteurs P1 ?\nPeut-on observer des troubles cognitifs avec les récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Récepteurs purinergiques P1", "description": "Comment prévenir les dysfonctionnements des récepteurs P1 ?\nL'alimentation influence-t-elle les récepteurs P1 ?\nLe stress a-t-il un impact sur les récepteurs P1 ?\nL'exercice physique aide-t-il les récepteurs P1 ?\nLes habitudes de sommeil influencent-elles les récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Récepteurs purinergiques P1", "description": "Quels traitements ciblent les récepteurs P1 ?\nLes thérapies géniques peuvent-elles affecter les récepteurs P1 ?\nY a-t-il des approches non médicamenteuses pour les récepteurs P1 ?\nLes anti-inflammatoires affectent-ils les récepteurs P1 ?\nComment les changements de mode de vie influencent-ils les récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Récepteurs purinergiques P1", "description": "Quelles complications peuvent survenir avec les récepteurs P1 ?\nLes maladies auto-immunes sont-elles liées aux récepteurs P1 ?\nLes troubles métaboliques sont-ils associés aux récepteurs P1 ?\nY a-t-il un risque accru de cancer avec les récepteurs P1 ?\nLes troubles de l'humeur sont-ils liés aux récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Récepteurs purinergiques P1", "description": "Quels facteurs de risque affectent les récepteurs P1 ?\nL'âge influence-t-il les récepteurs P1 ?\nLes maladies chroniques impactent-elles les récepteurs P1 ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLes infections peuvent-elles affecter les récepteurs P1 ?", "url": "https://questionsmedicales.fr/mesh/D018047?mesh_terms=Double-Blind+Method&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des récepteurs P1 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests fonctionnels et des analyses biochimiques spécifiques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les récepteurs P1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'activation cellulaire et des dosages d'adénosine peuvent être réalisés." } }, { "@type": "Question", "name": "Les imageries sont-elles utiles pour les récepteurs P1 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas directement utilisée pour les récepteurs P1, mais peut aider à évaluer des pathologies associées." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs pour les récepteurs P1 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour les récepteurs P1." } }, { "@type": "Question", "name": "Comment évaluer l'activité des récepteurs P1 ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'activité peut être évaluée par des tests de liaison et des études de signalisation intracellulaire." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysfonction des récepteurs P1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des troubles neurologiques, cardiovasculaires et inflammatoires." } }, { "@type": "Question", "name": "Les douleurs chroniques sont-elles associées aux récepteurs P1 ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activation anormale des récepteurs P1 peut contribuer à des douleurs chroniques." } }, { "@type": "Question", "name": "Y a-t-il des signes d'inflammation liés aux récepteurs P1 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les récepteurs P1 jouent un rôle dans la modulation de l'inflammation et peuvent être impliqués." } }, { "@type": "Question", "name": "Les troubles du sommeil sont-ils liés aux récepteurs P1 ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que les récepteurs P1 peuvent influencer les cycles de sommeil et l'éveil." } }, { "@type": "Question", "name": "Peut-on observer des troubles cognitifs avec les récepteurs P1 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une altération de la signalisation des récepteurs P1 peut être associée à des troubles cognitifs." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des récepteurs P1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain et éviter les facteurs de risque peut aider à prévenir ces dysfonctionnements." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle les récepteurs P1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction des récepteurs P1." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les récepteurs P1 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer la signalisation des récepteurs purinergiques P1." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il les récepteurs P1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la signalisation des récepteurs P1 et la santé globale." } }, { "@type": "Question", "name": "Les habitudes de sommeil influencent-elles les récepteurs P1 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon sommeil est crucial pour le fonctionnement optimal des récepteurs P1." } }, { "@type": "Question", "name": "Quels traitements ciblent les récepteurs P1 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les agonistes ou antagonistes de l'adénosine sont utilisés." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles affecter les récepteurs P1 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique pourrait potentiellement moduler l'expression des récepteurs P1." } }, { "@type": "Question", "name": "Y a-t-il des approches non médicamenteuses pour les récepteurs P1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la stimulation électrique peuvent influencer l'activité des récepteurs P1." } }, { "@type": "Question", "name": "Les anti-inflammatoires affectent-ils les récepteurs P1 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des récepteurs purinergiques P1." } }, { "@type": "Question", "name": "Comment les changements de mode de vie influencent-ils les récepteurs P1 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer la fonction des récepteurs P1 et réduire les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les récepteurs P1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles cardiovasculaires et neurologiques graves." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles liées aux récepteurs P1 ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysfonction des récepteurs P1 peut contribuer à des maladies auto-immunes." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils associés aux récepteurs P1 ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans la signalisation des récepteurs P1 peuvent être liées à des troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer avec les récepteurs P1 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que la dysfonction des récepteurs P1 pourrait être associée à un risque accru de cancer." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils liés aux récepteurs P1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une altération de la signalisation des récepteurs P1 peut être impliquée dans des troubles de l'humeur." } }, { "@type": "Question", "name": "Quels facteurs de risque affectent les récepteurs P1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le tabagisme, l'obésité et le stress peuvent affecter les récepteurs P1." } }, { "@type": "Question", "name": "L'âge influence-t-il les récepteurs P1 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut altérer la fonction des récepteurs purinergiques P1." } }, { "@type": "Question", "name": "Les maladies chroniques impactent-elles les récepteurs P1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent affecter la signalisation des récepteurs P1." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut nuire à la fonction des récepteurs P1." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter les récepteurs P1 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent altérer la signalisation des récepteurs purinergiques P1." } } ] } ] }

Sources (10000 au total)

Preemptive analgesia for hemorrhoidectomy: study protocol for a prospective, randomized, double-blind trial.

Hemorrhoidectomy is associated with intense postoperative pain that requires multimodal analgesia. It includes nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and local anesthetics to re... Patients of our clinic who meet the following inclusion criteria are included: hemorrhoids grade III-IV and the planned Milligan-Morgan hemorrhoidectomy. After signing the consent all participants are... Multimodality pain management has been shown to improve pain control and decrease opioid intake in patients after hemorrhoidectomy in several studies. Gabapentin can be considered as an alternative ap... ClinicalTrial.gov NCT04361695 . Registered on April 24, 2020, version 1.0....

Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.

Melatonin is effective for migraine prevention in adults. We hypothesized that melatonin would also be effective for migraine prevention in children and adolescents.... This was a randomized, double-blind trial of melatonin (3 mg or 6 mg) versus placebo for migraine prevention in 10-17 year-olds with 4-28/28 headache days at baseline. Participants were recruited from... The study closed early due to slow enrollment (n = 72). Two participants were in the single-blind phase when the study closed, therefore the meaningful n = 70. Sixteen percent (11/70) were lost to fol... When compared to recall at enrollment, headache days decreased across the single-blind placebo phase and the double-blind phase. There was no suggestion of superiority of melatonin; however, given the...

Clonidine augmentation in patients with schizophrenia: A double-blind, randomized placebo-controlled trial.

Noradrenergic imbalance in the brain of schizophrenia patients may underlie both symptomatology and deficits in basic information processing. The current study investigated whether augmentation with t... In a double-blind placebo-controlled randomized clinical trial, 32 chronic schizophrenia patients were randomly assigned to six-weeks augmentation with either 50 μg clonidine or placebo to their curre... Only patients treated with clonidine showed significantly reduced PANSS negative, general and total scores at follow-up compared to baseline. On average, also patients treated with placebo showed mino... Only patients treated with clonidine showed a significant decrease on two out of the three PANSS subscales, while additionally retained their levels of sensorimotor gating. Given that there are only a...

Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder.

Trichotillomania and skin-picking disorder are underrecognized and often disabling conditions in which individuals repeatedly pull at their hair or pick at their skin, leading to noticeable hair loss ... One hundred adults with trichotillomania or skin-picking disorder (86 women; mean age, 31.4 years [SD=10.2]) were enrolled in a double-blind trial of memantine (dosing range, 10-20 mg/day) or placebo ... Compared with placebo, memantine treatment was associated with significant improvements in scores on the NIMH scale, Sheehan Disability Scale, and Clinical Global Impressions severity scale in terms o... This study found that memantine treatment resulted in statistically significant reductions in hair pulling and skin-picking symptoms compared with placebo, with relatively high efficacy (based on numb...

Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.

Friedreich ataxia is (FRDA) an autosomal recessive neurodegenerative disorder associated with intrinsic oxidative damage, suggesting that decreasing lipid peroxidation (LPO) might ameliorate disease p... Sixty-five subjects were recruited across six sites and received either placebo or active drug for an 11-month study. Subjects were evaluated at 0, 4, 9, and 11 months, with the primary outcome measur... Forty-five subjects completed the protocol. RT001 was well tolerated, with no serious adverse events related to drug. Plasma and red blood cell (RBC) membrane levels of D2-LA and its primary metabolit... The results of this study provide no evidence for a significant benefit of RT001 at the dosages tested in this Friedreich ataxia patient population....

The effect of bromelain in periodontal surgery: a double-blind randomized placebo-controlled trial.

Periodontitis is a persistent inflammatory condition. Eliminating the infection and reducing its risk factors are the first steps in treating periodontitis. When the anti-infective therapy is complete... This double-blind randomized placebo-controlled trial included 28 candidates for pocket elimination surgery referred to the private office of a periodontist in Bandar Abbas, Iran, from April 18 to Aug... Four weeks after intervention, BOP was significantly lower with Anaheal compared to placebo (0% vs. 35.7%, P = 0.014). However, there was no significant difference in GI between groups (P = 0.120). Me... One-week treatment with Anaheal at a dose of 1 g/d after pocket elimination surgery resulted in significantly lower BOP compared to placebo.... Iranian Registry of Clinical Trials (IRCT), IRCT20201106049289N1. Registered 06/04/2021. Registered prospectively, https://www.irct.ir/trial/52181 ....

Topical Tranexamic Acid in Breast Reconstruction: A Double-Blind Randomized Controlled Trial.

Excess fluid accumulation (seroma/hematoma) around the breast implant after reconstruction can lead to significant complications. Topical administration of tranexamic acid (TXA) may reduce fluid accum... This paired, double-blind, randomized, controlled trial enrolled patients undergoing bilateral mastectomies with immediate direct-to-implant reconstruction. In each patient, one breast was randomized ... Fifty-three eligible patients, representing 106 breasts, were enrolled. All patients underwent bilateral nipple-sparing mastectomies. After randomization, TXA was placed in the right breast in 30 pati... Soaking the mastectomy bed with 3% topical TXA before implant insertion leads to a decrease in drain output and a decrease in complications. Topical administration of TXA represents an option to decre... Therapeutic, I....

Oral lactase for infantile colic: a randomized double-blind placebo-controlled trial.

Infantile colic is a common problem during the first three months of life. This randomized, double-blind, placebo-controlled trial conducted in an urban hospital in Delhi, India evaluated the efficacy... One hundred sixty-two clinically healthy infants aged < 5 months age [mean (SD) = 63.5 (30.5) days] fulfilling the Rome-IV diagnostic criteria for infantile colic were enrolled. Eligible children were... At the end of four weeks, mean (SD) crying or fussing time (min/d) was significantly shorter in infants receiving lactase in comparison to placebo [89.9 (115.2) vs.178.5 (153.2); P = 0.001]. The mean ... Oral lactase treatment in infantile colic results in symptomatic relief in terms of shortening of duration of crying or fussing, and better parental satisfaction.... Clinical trial registry of India (CTRI/2017/12/010930) registered on 20/12/2017....

Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial.

Intraoperative hemostasis should be performed with great caution because bleeding is a huge enemy of patient safety during surgery. Tranexamic acid is a lysine synthetic derivate that inhibits fibrino... The authors conducted a multicenter, double-blind, randomized, controlled clinical trial in patients who were scheduled for liposculpture in three plastic surgery centers (Colombia and Mexico) between... The authors found the intravenous intervention group to have a greater hemoglobin level than the other two groups on both the first postoperative day ( p = 0.0001) and the fifth postoperative day ( p ... Intravenous tranexamic acid is a good therapeutic choice to implement on liposculpture procedures to decrease postoperative bleeding.... The preoperative use of intravenous tranexamic acid not only decreases the bleeding rate after liposuction procedures, but also allows greater lipoaspirate volumes when performing high-definition lipo... Therapeutic, I....

Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.

Subcision method is one of the main techniques for treatment of acne scars or stromal-vascular fraction (SVF) and combined therapy can improve treatment strategy.... To use subcision method along with SVF for treatment of acne scar and comprised with alone subcision method.... In this double-blind clinical trial study, 10 patients with acne scars were entered into the study. Subcision technique was randomly performed on one side of the face and subcision technique plus SVF ... In terms of volume and area of scars, the mean percent change was 46.55 ± 13.92 and 44.60 ± 5.76, for the case group, and 13.31 ± 9.27 and 11.28 ± 9.64 for the control group, respectively. So, combine... According to the acquired results, combined therapy can be considered as effective and safe treatment for acne scars with significant higher efficacy compared with subcision alone....